A Japanese Bioventure Company's Application of Stem Cell Technology in Regenerative Medicine

Masanori Sawada, Daisuke Sugiyama, Takenobu Nii, Katsuhiro Konno, Hardy T.S. Kagimoto

    Research output: Contribution to journalArticle

    3 Citations (Scopus)

    Abstract

    Regenerative medicine mediated by the transplantation of somatic stem cells and functional cells derived from induced pluripotent stem cells has great potential in the treatment of currently incurable diseases and thus has attracted significant public attention. To put this into practice, several functional cell lines were developed and laws regarding regenerative medicine were put in force in Japan. In this report, we introduce recent efforts of a bioventure company with special attention to the case of Healios K.K.

    Original languageEnglish
    Pages (from-to)1801-1806
    Number of pages6
    JournalClinical Therapeutics
    Volume40
    Issue number11
    DOIs
    Publication statusPublished - Nov 2018

    All Science Journal Classification (ASJC) codes

    • Pharmacology
    • Pharmacology (medical)

    Fingerprint Dive into the research topics of 'A Japanese Bioventure Company's Application of Stem Cell Technology in Regenerative Medicine'. Together they form a unique fingerprint.

  • Cite this